DC-SIGN mediated antigen-targeting using glycan-modified liposomes: Formulation considerations

M.D. Joshi; W.W.J. Unger; A.J. van Beelen; S.C.M. Bruijns; M. Litjens; L. van Bloois; H. Kalay; Y. van Kooyk; G. Storm

doi:https://doi.org/10.1016/j.ijpharm.2011.02.055

DC-SIGN mediated antigen-targeting using glycan-modified liposomes: Formulation considerations

M.D. Joshi, W.W.J. Unger, A.J. van Beelen, S.C.M. Bruijns, M. Litjens, L. van Bloois, H. Kalay, Y. van Kooyk, G. Storm

Molecular cell biology and Immunology (VUmc)

Research output: Contribution to journal › Article › Academic › peer-review

30 Citations (Scopus)

Original language	Undefined/Unknown
Pages (from-to)	426-432
Journal	International Journal of Pharmaceutics
Volume	416
Issue number	2
DOIs	https://doi.org/10.1016/j.ijpharm.2011.02.055
Publication status	Published - 2011

Access to Document

https://doi.org/10.1016/j.ijpharm.2011.02.055

Cite this

@article{32f29da8e3a24059afb85c4f0357a520,

title = "DC-SIGN mediated antigen-targeting using glycan-modified liposomes: Formulation considerations",

author = "M.D. Joshi and W.W.J. Unger and {van Beelen}, A.J. and S.C.M. Bruijns and M. Litjens and {van Bloois}, L. and H. Kalay and {van Kooyk}, Y. and G. Storm",

year = "2011",

doi = "https://doi.org/10.1016/j.ijpharm.2011.02.055",

language = "Undefined/Unknown",

volume = "416",

pages = "426--432",

journal = "International Journal of Pharmaceutics",

issn = "0378-5173",

publisher = "Elsevier",

number = "2",

}

TY - JOUR

T1 - DC-SIGN mediated antigen-targeting using glycan-modified liposomes: Formulation considerations

AU - Joshi, M.D.

AU - Unger, W.W.J.

AU - van Beelen, A.J.

AU - Bruijns, S.C.M.

AU - Litjens, M.

AU - van Bloois, L.

AU - Kalay, H.

AU - van Kooyk, Y.

AU - Storm, G.

PY - 2011

Y1 - 2011

U2 - https://doi.org/10.1016/j.ijpharm.2011.02.055

DO - https://doi.org/10.1016/j.ijpharm.2011.02.055

M3 - Article

C2 - 21371544

SN - 0378-5173

VL - 416

SP - 426

EP - 432

JO - International Journal of Pharmaceutics

JF - International Journal of Pharmaceutics

IS - 2

ER -